VEGFA and breast neoplasm: It has been shown that Ang-(1-7) reduces the growth of human lung tumor xenografts, with a concomitant decrease in VEGF and reduced vessel density, as well as decreasing the growth of orthotopic human estrogen receptor–positive or HER2-overexpressing breast tumor xenografts [10, 53, 54].